SynthesisThe Cochrane database of systematic reviews2016
Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.
Synthesis in The Cochrane database of systematic reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Detection bias in open-label trials of anticancer drugs: a meta-epidemiological study.BMJ evidence-based medicine · 2023Pooled it
- Should we adjudicate outcomes in stroke trials? A systematic review.International journal of stroke : official journal of the International Stroke Society · 2023Pooled it
- Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study.BMJ (Clinical research ed.) · 2021Pooled it
- Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.The Cochrane database of systematic reviews · 2016Pooled it
- Trial
- Blinding of outcome assessors and its association with outcome in a randomized open-label stroke trial.International journal of stroke : official journal of the International Stroke Society · 2023Trial
- Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.Stroke · 2022Trial
- Trial
- Trial
- Guiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain.Journal of the American College of Cardiology · 2019Trial
- Trial
- Investigating the effect of independent, blinded digital image assessment on the STOP GAP trial.Trials · 2017Trial
- Using Dose-Escalation and -Expansion Cohort Study as Pivotal Trial for Targeted Anticancer Drug Approval.JCO precision oncology · 2025Review
- Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials.European heart journal · 2024Article
- The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development.JACC. Basic to translational science · 2024Review
- Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP).Kidney international reports · 2023Article
- The impact of blinding on trial results: A systematic review and meta-analysis.Cochrane evidence synthesis and methods · 2023Review
- Assessment of the Role of Artificial Intelligence in the Association Between Time of Day and Colonoscopy Quality.JAMA network open · 2023Article
- GLASS(Y) Half-Full: Moving Towards Greater Pragmatism in Outcome Ascertainment for Clinical Trials.Circulation. Cardiovascular quality and outcomes · 2021Article
- Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification.European stroke journal · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAssessment of events by adjudication committees (ACs) is recommended in multicentre randomised controlled trials (RCTs). However, its usefulness has been questioned.
objectivesThe aim of this systematic review was to compare 1) treatment effect estimates of subjective clinical events assessed by onsite assessors versus by AC, and 2) treatment effect estimates according to the blinding status of the onsite assessor as well as the process used to select events to adjudicate. SEARCH
methodsWe searched Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, PsycINFO, CINAHL and Google Scholar (25 August 2015 as the last updated search date), using a combination of terms to retrieve RCTs with commonly used terms to describe ACs. SELECTION CRITERIA: We included all reports of RCTs and the published RCTs included in reviews and meta-analyses that reported the same subjective outcome event assessed by both an onsite assessor and an AC. DATA COLLECTION AND ANALYSIS: We extracted the odds ratio (OR) from onsite assessment and the corresponding OR from AC assessment and calculated the ratio of the odds ratios (ROR). A ratio of odds ratios < 1 indicated that onsite assessors generated larger effect estimates in favour of the experimental treatment than ACs. MAIN
resultsData from 47 RCTs (275,078 patients) were used in the meta-analysis. We excluded 11 RCTs because of incomplete outcome data to calculate the OR for onsite and AC assessments. On average, there was no difference in treatment effect estimates from onsite assessors and AC (combined ROR: 1.00, 95% confidence interval (CI) 0.97 to 1.04; I(2) = 0%, 47 RCTs). The combined ROR was 1.00 (95% CI 0.96 to 1.04; I(2) = 0%, 35 RCTs) when onsite assessors were blinded; 0.76 (95% CI 0.48 to 1.12, I(2) = 0%, two RCTs) when AC assessed events identified independently from unblinded onsite assessors; and 1.11 (95% CI 0.96 to 1.27, I(2) = 0%, 10 RCTs) when AC assessed events identified by unblinded onsite assessors. However, there was a statistically significant interaction between these subgroups (P = 0.03) AUTHORS'
conclusionsOn average, treatment effect estimates for subjective outcome events assessed by onsite assessors did not differ from those assessed by ACs. Results of subgroup analysis showed an interaction according to the blinded status of onsite assessors and the process used to submit data to AC. These results suggest that the use of ACs might be most important when onsite assessors are not blinded and the risk of misclassification is high. Furthermore, research is needed to explore the impact of the different procedures used to select events to adjudicate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.